Profiling rogue B cell clones in autoimmune disease using single-cell RNA-sequencing
Mandeep Singh1, J.H. Reed1, S. Rizzetto2, A.A. Eltahla2, C. Cai2, F. Luciani2, C.C. Goodnow1
1Department of Immunology, Garvan Institute of Medical Research, Australia;
2Kirby Institute for Infection and Immunity, Australia
The B cell receptor (BCR) is crucial for B cell development, survival, and activation. Multiple immune tolerance mechanisms ensure that B cells carrying self-reactive BCRs are either purged during development or inactivated in the periphery. How these self-reactive “rogue” B cell clones break tolerance mechanisms and drive disease in autoimmune disorders is poorly understood. The recent emergence of single-cell technologies offers a powerful way to profile rogue cells within highly dynamic and heterogeneous immune populations. In particular, single-cell RNA-sequencing (scRNA-seq) of B or T lymphocytes allows for both the measurement of gene expression and immune repertoire information at single-cell resolution. We developed a novel computation pipeline to assemble full-length heavy and light chain BCR sequences from scRNA-seq using an updated version of the tool VDJPuzzle. We applied our approach to an Sjögren’s syndrome patient presenting IGHV1-69 IgM Rheumatoid Factor autoantibodies and an expanded IGHV1-69+ memory B cell population that persisted longitudinally. Sc-RNA-seq followed by BCR assembly of IGHV1-69+ memory B cells revealed identical V, J and D segments and two extremely similar CDR3 sequences within each heavy and light chain. In contrast, IGHV1-69- memory B cells sorted from the same patient were found to express a polyclonal repertoire. Transcriptome profiling coupled with surface phenotype markers additionally revealed that IGHV1-69+ memory B cells have a distinct phenotype when compared to clonally unrelated cells. These results show that scRNA-seq can be used to characterise a pathogenic B cell clone in an autoimmune disease patient. Profiling rogue B cells and understanding the pathways that are deregulated will help understand the complexity of autoimmune disease pathogenesis and may led to new approaches for targeted therapy.
You must be logged in and own this product in order to post comments.